Can gold-based nanotechnology meet the need for neuro-reparative therapies in MS?
Robert Glanzman • 1 Mar 2021
Recommended standards of care for adult patients with spinal muscular atrophy
Anna Kostera-Pruszczyk • 25 Jun 2022
Long term safety and efficacy data for ravulizumab in AChR Ab+ generalized myasthenia gravis
James F. Howard Jr. • 12 Apr 2022